Congresswoman Marjorie Taylor Greene criticized the FDA’s approval of Moderna’s new lower-dose COVID-19 vaccine, mNEXSPIKE, deeming it inconsistent with Robert F. Kennedy Jr.’s “Make America Healthy Again” initiative. The vaccine, approved for high-risk individuals aged 12 and older, follows a Phase 3 clinical trial and aims to combat ongoing COVID-19 threats. This announcement comes amidst shifting CDC guidance on COVID-19 vaccination for pregnant women and healthy children, a change welcomed by Kennedy Jr. Moderna’s CEO lauded the approval as adding a crucial tool in protecting vulnerable populations.
Read More
The Centers for Disease Control and Prevention (CDC) has directly contradicted Robert F. Kennedy Jr.’s recent decision to remove Covid-19 vaccines from the federal immunization schedule for children. The CDC has maintained its recommendation that children aged 6 months to 17 years may receive the Covid-19 vaccine.
This stance, however, is presented with a crucial caveat. The CDC now emphasizes “shared decision-making,” meaning that the decision to vaccinate a child rests on consultation between the child’s caregiver and their healthcare provider. This approach suggests a move towards a more individualized and collaborative approach to vaccination.
The CDC’s updated guidance also clarifies the availability of Covid-19 vaccines for children participating in the Vaccines for Children program.… Continue reading
John Q. Hosedrinker 
Matt Underwood